MindBio Therapeutics Corp.
MBIO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -396.10K | -175.00K | -267.30K | -2.37M | -2.63M |
| Total Depreciation and Amortization | 57.80K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 209.20K | 62.50K | 130.20K | 1.52M | 1.28M |
| Change in Net Operating Assets | 61.90K | 51.30K | -113.20K | 204.90K | 336.40K |
| Cash from Operations | -67.30K | -61.30K | -250.40K | -641.50K | -1.01M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -13.50K | -40.00K |
| Total Debt Repaid | -20.60K | -20.60K | -12.60K | -107.60K | -107.60K |
| Issuance of Common Stock | 165.00K | -- | -- | 377.40K | 1.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 284.80K | 590.90K | 284.80K |
| Cash from Financing | 93.80K | -13.70K | 178.20K | 562.20K | 861.30K |
| Foreign Exchange rate Adjustments | -45.60K | -45.60K | -45.60K | 117.30K | 117.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.00K | -120.60K | -117.80K | 38.10K | -30.90K |